Latest return on equity
Kalaris Therapeutics Return on equity
Direct answer
Kalaris Therapeutics's return on equity is -79.91%.
The verified market snapshot reports -79.91%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 26, 2026.
Get free Kalaris Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -79.91%
Explore related company data
View Kalaris Therapeutics's market capitalizationView Kalaris Therapeutics's price-to-book ratioView Kalaris Therapeutics's dividend yieldView Kalaris Therapeutics's 52-week price rangeView Kalaris Therapeutics's profit marginView Kalaris Therapeutics's debt-to-equity ratioView all Kalaris Therapeutics key metricsReturn to Kalaris Therapeutics profile